Ulrich Goepfert

This inventor holds 27 USPTO granted patents and 18 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Bispecific Antibodies. Top assignee: Hoffmann-La Roche Inc.. Active years: 2011-2026.

USPTO Granted Patents = 27 (Patent Applications = 18)

% Patents Active = 85.2

CIPO Patents = 5 (Patent Applications = 14)

EPO Patents = 14 (Patent Applications = 27)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 143(Granted Patents)

Location History:

Munich, DE (2011 - 2016)
Penzberg, DE (2013 - 2024)

Company Filing History:

26 out of 5,020

Hoffmann-La Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-Human A-Beta

Transferrin Receptor

Nucleic Acid Constructs

Humanized Antibodies

Protein Expression

Cell Selection

Immunoglobulin Production

Antibody Screening

Brain Diseases

Affinity Engineering

Recombinase Mediated Cassette Exchange

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735497 - BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE (2026-09-15),

2. 12529050 - MULTISPECIFIC ANTIBODY SCREENING METHOD USING RECOMBINASE MEDIATED CASSETTE EXCHANGE (2026-01-20),

3. 12358997 - Bispecific anti-human A-beta/anti-human transferrin receptor antibodies (2025-07-15),

4. 12312606 - Nucleic acid constructs for VA RNA transcription (2025-05-27),

5. 12297263 - Humanized anti-Tau(PS422) antibodies and methods of use (2025-05-13),

6. 12252533 - Anti-transferrin receptor antibodies with tailored affinity (2025-03-18),

7. 12030952 - Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use (2024-07-09),

8. 11787868 - Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use (2023-10-17),

9. 11603411 - Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use (2023-03-14),

10. 11584793 - Anti-transferrin receptor antibodies with tailored affinity (2023-02-21),

11. 11572404 - Humanized anti-Tau(pS422) antibodies and methods of use (2023-02-07),

12. 11332797 - Method for the selection of a long-term producing cell using histone acylation as markers (2022-05-17),

13. 10941205 - Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use (2021-03-09),

14. 10822402 - Humanized anti-tau(pS422) antibodies and methods of use (2020-11-03),

15. 10465000 - Humanized anti-Tau(pS422) antibodies and methods of use (2019-11-05),

Title: Inventor Ulrich Goepfert

Introduction: Ulrich Goepfert is a renowned inventor based in Penzberg, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Ulrich Goepfert holds several patents in the areas of renewable energy, sustainable technologies, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Ulrich Goepfert has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on society.

Collaborations: Throughout his career, Ulrich Goepfert has collaborated with top scientists, engineers, and inventors globally, fostering a culture of creativity and excellence in his projects.

Conclusion: Ulrich Goepfert's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.